HomeAIP • JSE
add
Adcock Ingram Holdings Limited
Previous close
ZAC 7,272.00
Day range
ZAC 7,260.00 - ZAC 7,323.00
Year range
ZAC 4,301.00 - ZAC 7,396.00
Market cap
11.72B ZAR
Avg Volume
143.74K
P/E ratio
12.73
Dividend yield
3.85%
Primary exchange
JSE
Financials
Income Statement
Revenue
Net income
| (ZAR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.52B | 2.92% |
Operating expense | 500.18M | 1.81% |
Net income | 234.40M | 26.76% |
Net profit margin | 9.29 | 23.21% |
Earnings per share | — | — |
EBITDA | 366.53M | 9.35% |
Effective tax rate | 24.93% | — |
Balance Sheet
Total assets
Total liabilities
| (ZAR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 104.07M | 16.38% |
Total assets | 8.74B | 4.56% |
Total liabilities | 2.90B | -1.35% |
Total equity | 5.83B | — |
Shares outstanding | 146.76M | — |
Price to book | 1.83 | — |
Return on assets | 9.29% | — |
Return on capital | 13.35% | — |
Cash Flow
Net change in cash
| (ZAR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 234.40M | 26.76% |
Cash from operations | 511.59M | 54.30% |
Cash from investing | -49.12M | -87.45% |
Cash from financing | -95.75M | 57.09% |
Net change in cash | 366.32M | 345.19% |
Free cash flow | 262.28M | -3.34% |
About
Adcock Ingram is a South African pharmaceutical manufacturer listed on the Johannesburg Stock Exchange. Adcock Ingram manufactures and markets healthcare products to both the private and public sectors. Wikipedia
CEO
Founded
1890
Headquarters
Website
Employees
2,436
